Posted by Michael Wonder on 13 Dec 2018
Authorized generic for Evzio (naloxone hydrochloride injection) to be available at a reduced list price of $178
12 December 2018 - Product will be available in 2019.
Kaléo today announced that it will offer an authorised generic of its Evzio (naloxone hydrochloride injection) take home naloxone product at a list price of $178 per carton (each carton contains two auto-injectors).
Offered through Kaléo subsidiary IJ Therapeutics, the authorised generic will be made available in mid-year 2019 well in advance of Evzio's patent expirations. The authorised generic for Evzio is the same formulation, design and meets all of the same high standards of quality as the branded drug but will have a different label. Kaléo will continue to market and distribute Evzio.
